Fingolimod Hydrochloride
2 NDCs across 2 manufacturers|2 Generic,0 Brand
Fingolimod Hydrochloride is used to treat relapsing-remitting multiple sclerosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 21, 2010, and the first generic was approved Dec 4, 2019. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient.
Fingolimod Hydrochloride is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $1.58 to $3.56 per EA — the most expensive product costs about 2.3× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
2
competing in market
Price Spread
$1.58 – $3.56
per EA
7d Activity
avg -24.7% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Accord Healthcare Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Sphingosine 1-phosphate Receptor Modulator class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing FINGOLIMOD HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FINGOLIMOD 0.5 MG CAPSULE | $3.5631 per EA | — |
FINGOLIMOD 0.5 MG CAPSULE | $1.5791 per EA | -24.71% |
Frequently Asked Questions
What is Fingolimod Hydrochloride used to treat?
Fingolimod Hydrochloride is used to treat relapsing-remitting multiple sclerosis, per the National Library of Medicine's MED-RT classification.
When did Fingolimod Hydrochloride become available as a generic?
FDA approved the first generic Fingolimod Hydrochloride (ANDA) on Dec 4, 2019. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Fingolimod Hydrochloride products are on the market?
The Fingolimod Hydrochloride drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.
What is the price range for Fingolimod Hydrochloride?
NADAC reference prices for Fingolimod Hydrochloride range from $1.5791 to $3.5631 per EA — the most expensive product costs about 2.3× the cheapest.
Which manufacturers make Fingolimod Hydrochloride?
2 manufacturers list Fingolimod Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Accord Healthcare Inc. (1), Ascend Laboratories, LLC (1).
How has the price of Fingolimod Hydrochloride changed recently?
Over the past 7 days, 0 Fingolimod Hydrochloride NDCs rose and 1 fell, with a market-wide average change of -24.7%.